-
Once intensive care practices have been well standardized, patient safety becomes one of the biggest issues in the ICU in terms of management of health care quality (affecting the outcomes of patients admitted to the ICUs). The acquisition of nosocomial infections in the ICU is known to significantly affect patient outcomes such as ICU and hospital mortality and length of ICU and hospital stays.
-
Neuropsychiatric Symptoms of Dementia, FDA Actions.
-
-
-
Trying to head off a patchwork of mandatory infection-rate disclosure laws that vary from state to state, the Centers for Disease Control and Prevention (CDC) has created a guidance document to serve as a template for new state laws or a national reporting system.
-
A draft guidance document by the Centers for Disease Control and Preventions Healthcare Infection Control Practices Advisory Committee (HICPAC) includes the following executive summary and four overarching recommendations.
-
A draft guidance document by the Centers for Disease Control and Preventions Healthcare Infection Control Practices Advisory Committee recommended three process measures for mandatory public reporting systems on health care-associated infections.
-
A draft guidance document by the Centers for Disease Control and Preventions Healthcare Infection Control Practices Advisory Committee recommended two outcome measures for mandatory public reporting systems on health care-associated infections. The draft lists the following details on the those selections, including measures, rationale for inclusion, and potential limitations.
-
The Joint Commission on Accreditation of Healthcare Organizations has set patient safety goals for 2005 that include several high-profile infection control issues. The goals include high compliance with hand hygiene; reducing influenza and pneumonia in long-term care; and a continuation of the controversial edict to investigate patient deaths linked to nosocomial infections.
-
The Joint Commission on Accreditation of Healthcare Organizations has set a 2005 patient safety goal for long-term settings to reduce the risk of influenza and pneumococcal disease. ICPs in such settings should develop and implement a protocol for administration and documentation of both the influenza vaccine and the pneumococcal vaccine.
